Benchling

Benchling enables faster drug discovery and development by streamlining research workflows, helping scientists move promising compounds forward more quickly. Clinical drug development accelerates by up to 50% using digital R&D platforms like Benchling, getting life-saving treatments to patients sooner.

Benchling provides standardized, reproducible research data from integrated platforms that capture complete experimental traceability. This enables physicians to access high-quality evidence for treatment decisions backed by GxP-compliant workflows and complete data integrity throughout the drug development process.

Hospitals adopting integrated R&D platforms report up to 4X productivity increases and 67% reduction in collaboration overhead. Scientists save nearly one day per week per person, and organizations achieve faster IND submission timelines and accelerated time-to-market for new therapies.

Benchling serves 1,200+ biotech organizations and more than half of the world's top 50 biopharma companies including Moderna, Sanofi, Gilead, and AstraZeneca. The platform has demonstrated consistent growth: Series D raised $50M in 2020, Series F raised $100M, with customers adding $150+ new organizations per funding cycle.